Skip to content
healthcare.dev
Get a free key

INLEXZO

NDC 57894-225, gemcitabine intravesical, system, from Janssen Biotech, Inc.

Product NDC
57894-225
Status
Listed
Labeler
Janssen Biotech, Inc
Dosage form
SYSTEM
Route
INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219683
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMCITABINE225 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
57894-225-01578940225011 SYSTEM in 1 BOX (57894-225-01)
57894-225-99578940225991 SYSTEM in 1 BOX (57894-225-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-225

Use it

Look up 57894-225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.